Patents by Inventor Michael Zaworotko

Michael Zaworotko has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230285932
    Abstract: A method of capturing water from a composition comprising water or water vapour using a hybrid ultramicroporous material. The method comprises the steps of: (a) providing a hybrid ultramicroporous material of formula [M(L)a(X)b]; and (b) contacting the hybrid ultramicroporous material with the composition comprising water to capture water into the hybrid ultramicroporous material; The hybrid ultramicroporous materials used in the method of the present invention have fast kinetics of water uptake and high working capacity compared to known commercial sorbent materials. The method of the present invention may be used in water capture and purification processes to provide fresh water suitable for drinking or for use in agriculture. The method of the present invention may also be used to remove water as a contaminant or for use in dehumidification processes. A use of such a hybrid ultramicroporous material and a device for capturing water are also disclosed.
    Type: Application
    Filed: March 19, 2021
    Publication date: September 14, 2023
    Inventors: Yun-Lei PENG, Shiqiang WANG, Michael ZAWOROTKO, Shaza DARWISH, Andrey BEZRUKOV
  • Publication number: 20230234972
    Abstract: Stable crystal forms comprising lithium ions and the conjugate base of an organic acid which is in the form of anhydrous coordination polymer that exhibit improved in vivo performance with respect to lithium carbonate.
    Type: Application
    Filed: March 24, 2023
    Publication date: July 27, 2023
    Inventors: Michael Zaworotko, Miranda Perry, Renato Lajarim Carneiro, Naga Duggirala, Dan O'Nolan, Peraka Krishna
  • Patent number: 11058985
    Abstract: A method of separating acetylene from a gas mixture comprising acetylene is provided. The method involves the use of a hybrid porous material with an affinity for acetylene adsorption. The hybrid porous material comprises a three-dimensional structure of metal species (M) and first and second linker groups (L1 and L2), wherein the metal species (M) are linked together in a first and second direction by first linker groups (L1) and are linked together in a third direction by second linker groups (L2) to form the three-dimensional structure. The hybrid porous materials may have a high selectivity for acetylene and/or a high capacity for acetylene adsorption. The method may be particularly useful for the purification of ethylene gas contaminated with acetylene during an ethylene production/purification process. The method may be particularly useful for the large scale separation of acetylene from other gases such as ethylene and carbon dioxide, during an acetylene production/purification process.
    Type: Grant
    Filed: February 2, 2016
    Date of Patent: July 13, 2021
    Assignees: UNIVERSITY OF LIMERICK, UNIVERSITY OF TEXAS AT SAN ANTONIO, ZHEJIANG UNIVERSITY
    Inventors: Huabin Xing, Xili Cui, Michael Zaworotko, Kai Jie Chen, Banglin Chen
  • Publication number: 20190382419
    Abstract: Stable crystal forms comprising lithium ions and the conjugate base of an organic acid which is in the form of anhydrous coordination polymer that exhibit improved in vivo performance with respect to lithium carbonate.
    Type: Application
    Filed: April 28, 2017
    Publication date: December 19, 2019
    Inventors: Michael Zaworotko, Miranda Perry, Renato Lajarim Carneiro, Naga Duggirala, Dan O'Nolan, Peraka Krishna
  • Publication number: 20190054413
    Abstract: A method of separating acetylene from a gas mixture comprising acetylene is provided. The method involves the use of a hybrid porous material with an affinity for acetylene adsorption. The hybrid porous material comprises a three-dimensional structure of metal species (M) and first and second linker groups (L1 and L2), wherein the metal species (M) are linked together in a first and second direction by first linker groups (L1) and are linked together in a third direction by second linker groups (L2) to form the three-dimensional structure. The hybrid porous materials may have a high selectivity for acetylene and/or a high capacity for acetylene adsorption. The method may be particularly useful for the purification of ethylene gas contaminated with acetylene during an ethylene production/purification process. The method may be particularly useful for the large scale separation of acetylene from other gases such as ethylene and carbon dioxide, during an acetylene production/purification process.
    Type: Application
    Filed: February 2, 2016
    Publication date: February 21, 2019
    Inventors: Huabin XING, Xili CUI, Michael ZAWOROTKO, Kai Jie CHEN, Banglin CHEN
  • Patent number: 9676807
    Abstract: Embodiments of the present disclosure provide for multi-component metal-organic materials (MOMs), systems including the MOM, systems for separating components in a gas, methods of separating polarizable gases from a gas mixture, and the like.
    Type: Grant
    Filed: October 31, 2013
    Date of Patent: June 13, 2017
    Assignee: University of South Florida
    Inventors: Michael Zaworotko, Mona H. Mohamed, Sameh Elsaidi
  • Patent number: 9504986
    Abstract: Embodiments of the present disclosure provide for multi-component metal-organic materials (MOMs) systems that exhibit permanent porosity and using MOMs to separate components in a gas mixture, methods of separating polarizable gases from a gas mixture, and the like.
    Type: Grant
    Filed: November 7, 2013
    Date of Patent: November 29, 2016
    Assignee: University of South Florida
    Inventors: Michael Zaworotko, Patrick Nugent, Vanessah Rhodus
  • Publication number: 20150291641
    Abstract: Embodiments of the present disclosure provide for multi-component metal-organic materials (MOMs), systems including the MOM, systems for separating components in a gas, methods of separating polarizable gases from a gas mixture, and the like.
    Type: Application
    Filed: October 31, 2013
    Publication date: October 15, 2015
    Inventors: Michael Zaworotko, Mona H. Mohamed, Sameh Elsaidi
  • Publication number: 20150246340
    Abstract: Embodiments of the present disclosure provide for multi-component metal-organic materials (MOMs) systems that exhibit permanent porosity and using MOMs to separate components in a gas mixture, methods of separating polarizable gases from a gas mixture, and the like.
    Type: Application
    Filed: November 7, 2013
    Publication date: September 3, 2015
    Applicant: University of South Florida
    Inventors: Michael Zaworotko, Patrick Nugent, Vanessah Rhodus
  • Patent number: 8471044
    Abstract: Crystalline epigallocatechin-3-gallate compositions and methods of use.
    Type: Grant
    Filed: June 6, 2008
    Date of Patent: June 25, 2013
    Assignee: University of South Florida
    Inventors: Michael Zaworotko, Sheshanka Kesani
  • Patent number: 8034952
    Abstract: The present invention generally relates to supramolecular assemblies and their modes of synthesis. The supramolecular assemblies include a 1:8 ratio of a supermolecular polyhedral building block and a triangular molecular building block, the supermolecular polyhedral building block having points of extension corresponding to the vertices of a rhombicuboctahedron for linking the supermolecular polyhedral building block to the triangular building block.
    Type: Grant
    Filed: November 17, 2008
    Date of Patent: October 11, 2011
    Assignee: University of South Florida
    Inventors: Mohamed Eddaoudi, Farid Nouar, Jarrod F. Eubank, Lukasz Wojtas, Till Bousquet, Michael Zaworotko
  • Publication number: 20100204204
    Abstract: Co-crystals comprising at least one nutraceutical compound and at least one co-crystal former with or without impurities. These co-crystals may be included in compositions (optionally also including other components such as pharmaceutically acceptable excipients, other nutritional supplements, etc.) having utility as pharmaceuticals, nutraceuticals, nutritional supplements, and foodstuffs.
    Type: Application
    Filed: June 6, 2008
    Publication date: August 12, 2010
    Applicant: UNIVERSITY OF SOUTH FLORIDA
    Inventors: Michael Zaworotko, Heather Clarke, Arora Kapildev, Padmini Kavuru, Roland Douglas Shytle, Twarita Pujari, Lissette Marshall, Tien Teng Ong
  • Publication number: 20100173984
    Abstract: Crystalline epigallocatechin-3-gallate compositions and methods of use.
    Type: Application
    Filed: June 6, 2008
    Publication date: July 8, 2010
    Applicant: UNIVERSITY OF SOUTH FLORIDA
    Inventors: Michael Zaworotko, Sheshanka Kesani
  • Publication number: 20090143596
    Abstract: The present invention generally relates to supramolecular assemblies and their modes of synthesis. The supramolecular assemblies include a 1:8 ratio of a supermolecular polyhedral building block and a triangular molecular building block, the supermolecular polyhedral building block having points of extension corresponding to the vertices of a rhombicuboctahedron for linking the supermolecular polyhedral building block to the triangular building block.
    Type: Application
    Filed: November 17, 2008
    Publication date: June 4, 2009
    Applicant: University of South Florida
    Inventors: Mohamed Eddaoudi, Farid Nouar, Jarrod F. Eubank, Lukasz Wojtas, Till Bousquet, Michael Zaworotko
  • Publication number: 20070299033
    Abstract: The present invention comprises pharmaceutical compositions comprising a co-crystal of an API and a co-crystal former, and methods of making and using the same.
    Type: Application
    Filed: June 16, 2005
    Publication date: December 27, 2007
    Applicants: Trans Form Pharmaceuticals, Inc., University of South Florida
    Inventors: Jennifer McMahon, Matthew Peterson, Michael Zaworotko, Tanise Shattock, Magali Bourghol Hickey
  • Publication number: 20070059356
    Abstract: A pharmaceutical composition comprising a co-crystal of an API and a co-crystal former; wherein the API has at least one functional group selected from ether, thioether, alcohol, thiol, aldehyde, ketone, thioketone, nitrate ester, phosphate ester, thiophosphate ester, ester, thioester, sulfate ester, carboxylic acid, phosphinic acid, phosphonic acid, sulfonic acid, amide, primary amine, secondary amine, ammonia, tertiary amine, imine, thiocyanate, cyanamide, oxime, nitrile diazo, organohalide, nitro, S-heterocyclic ring, thiophene, N-heterocyclic ring, pyrrole, 0-heterocyclic ring, furan, epoxide, peroxide, hydroxamic acid, imidazole, pyridine and the co-crystal former has at least one functional group selected from amine, amide, pyridine, imidazole, indole, pyrrolidine, carbonyl, carboxyl, hydroxyl, phenol, sulfone, sulfonyl, mercapto and methyl thio, such that the API and co-crystal former are capable of co-crystallizing from a solution phase under crystallization conditions.
    Type: Application
    Filed: February 26, 2004
    Publication date: March 15, 2007
    Inventors: Örn Almarsson, Magali Bourghol Hickey, Matthew Peterson, Michael Zaworotko, Brian Moulton, Nair Rodriguez-Hornedo
  • Publication number: 20070026078
    Abstract: A pharmaceutical composition comprising a co-crystal of an API and a co-crystal former; wherein the API has at least one functional group selected from ether, thioether, alcohol, thiol, aldehyde, ketone, thioketone, nitrate ester, phosphate ester, thiophosphate ester, ester, thioester, sulfate ester, carboxylic acid, phosphonic acid, phosphinic acid, sulfonic acid, amide, primary amine, secondary amine, ammonia, tertiary amine, sp2 amine, thiocyanate, cyanamide, oxime, nitrile diazo, organohalide, nitro, s-heterocyclic ring, thiophene, n-heterocyclic ring, pyrrole, o-heterocyclic ring, furan, epoxide, peroxide, hydroxamic acid, imidazole, pyridine and the co-crystal former has at least one functional group selected from amine, amide, pyridine, imidazole, indole, pyrrolidine, carbonyl, carboxyl, hydroxyl, phenol, sulfone, sulfonyl, mercapto and methyl thio, such that the API and co-crystal former are capable of co-crystallizing from a solution phase under crystallization conditions.
    Type: Application
    Filed: September 11, 2003
    Publication date: February 1, 2007
    Applicants: TransForm Pharmaceuticals, Inc., University of South Florida, The Regents of the University of Michigan
    Inventors: Orn Almarsson, Magali Bourghol Hickey, Matthew Peterson, Michael Zaworotko, Brian Moulton, Nair Rodriguez-Hornedo